These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2289219)
1. Nifedipine retard in the treatment of hypertension. A study using ambulatory blood pressure recordings. Hwang YS Clin Ther; 1990; 12(6):503-12. PubMed ID: 2289219 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension. Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609 [TBL] [Abstract][Full Text] [Related]
4. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension. Manyemba J Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111 [TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537 [TBL] [Abstract][Full Text] [Related]
6. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard. Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287 [TBL] [Abstract][Full Text] [Related]
7. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump. de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial. Harder S; Rietbrock S; Thürmann P Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945 [TBL] [Abstract][Full Text] [Related]
10. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring. Granberry MC; Gardner SF; Schneider EF; Carter IR Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients. Ding YA; Law HW; Chou TC J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension. Kirby BJ; Kitchin NR Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension. Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension]. Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension. Fagan TC; Haggert BE; Liss C Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251 [TBL] [Abstract][Full Text] [Related]
17. Slow-release metoprolol and nifedipine in essential hypertension: 24 hour noninvasive ambulatory blood pressure monitoring. Lattuada S; Antivalle M; Rindi M; Montanari M; Alberti D; Libretti A J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S99-101. PubMed ID: 2455155 [TBL] [Abstract][Full Text] [Related]
18. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817 [TBL] [Abstract][Full Text] [Related]
19. Combination of nifedipine and carteolol compared to nifedipine alone in diurnal blood pressure variation and exercise blood pressure in patients with essential hypertension. Inoue I; Matsuura H; Fujii T; Ishida T; Ozono R; Kainouchi M; Tsuchioka Y; Kajiyama G Clin Ther; 1992; 14(1):22-9. PubMed ID: 1576623 [TBL] [Abstract][Full Text] [Related]
20. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study. Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]